CRO

The CRO (Contract Research Organization) theme covers companies providing outsourced R&D and clinical development services to biopharma. Core tracks include discovery and preclinical testing, clinical trial operations and site management, data management/biostatistics, regulatory and pharmacovigilance, and central lab services.The sector's total market cap is 297.53 billion HKD, with a 24h change of -0.31%. Among 9 constituents, 2 are up (22.22%) and 6 are down (66.67%). The top gainer is FANGDA HOLDING (01521), with a 24h increase of +0.87%.Tone firm with improving breadth and quality leadership. Trade leaders near term; add selectively in sync with earnings cadence and rate trends.